Clinical Trial Update: Study of CTS-1027 in Hepatitis C Patients [Phase 2]

View source ↗

Summary

Conatus Pharmaceuticals' Phase 2 trial of CTS-1027 in patients with chronic hepatitis C infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CTS-1027

Snippet

Sponsor: Conatus Pharmaceuticals Inc. | Conditions: Chronic Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED